Biotron (ASX:BIT) raised AU$1.3 million through the completion of its renounceable rights issue, according to a Tuesday filing with the Australian bourse.
The company will issue 424.9 million new fully paid ordinary shares, with AU$668,336 raised from rights taken up and AU$606,253 from shortfall shares, the filing said.
Proceeds will be used to support Biotron's commercialization efforts, as well as general working capital, the filing added.
The new shares will be issued on April 8, the company said.
Mahe Capital was the lead manager and underwriter for the rights issue.
Shares of the company declined 13% in recent Tuesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.